BioCentury
ARTICLE | Company News

American Biogenetic, New Horizons Diagnostics Corp. deal

June 22, 1998 7:00 AM UTC

The companies will develop a point-of-care platform for a set of tests, including MABXA's Thrombus Precursor Protein kit, a monoclonal antibody-based blood clot risk test that detects soluble fibrin....